Materials
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) was purchased from Sigma and used as received. Uridine acetonide, 2-chloro-2-oxo-1,3,2-dioxaphospholane, 2'-deoxyadenosine, oleic acid and 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) were purchased from Sigma-Aldrich and used without further purification. Trimethylamine (ca. 13% in tetrahydrofuran (THF), ca. 2 mol/L) and myristic acid were used as purchased from TCI. 1-Ethyl-3-(3-dimethyllaminopropyl)carbodiimide hydrochloride (EDC) and 4-dimethylaminopyridine (DMAP) were purchased from Aladdin. THF was dried by refluxing with the fresh sodium-benzophenone complex under N 2 and distilled just before use.
Triethylamine (TEA) and dichloromethane were treated with calcium hydride and distilled before use. Doxorubicin hydrochloride (DOX) was purchased from Beijing Huafeng United Technology Corporation and used as received. Clear polystyrene tissue culture treated 12-well and 96-well plates were obtained from Corning Costar.
β-Actin polyclonal antibodies and Caspase-7 polyclonal antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). PARP polyclonal antibodies were purchased from Abcam (Hong Kong) Ltd. All other reagents and solvents were purchased from the domestic suppliers and used as received unless mentioned.
Measurements
Nuclear magnetic resonance (NMR). All NMR spectra were recorded on Bruker AVANCEIII 400 spectrometer with deuterium oxide (D 2 O), dimethylsulfoxide-d 6 (DMSO-d 6 ) or deuterated chloroform (CDCl 3 ) as solvents ( 1 H at 400 MHz, 13 C at 100 S4 MHz and 31 P at 162 MHz).
Mass spectrometry (MS)
. MS experiments were carried out on a Waters Premier Q-TOF, employing electrospray ionization in positive mode.
Dynamic light scattering (DLS). DLS measurements were performed with a Malvern Zetasizer Nano S apparatus equipped with a 4.0 mW laser operating at ë = 633 nm. All samples were measured at a scattering angle of 173°. The data were the mean of three tests.
Transmission electron microscopy (TEM). The structure and size of liposomes were characterized by a JEOL JEM-100CX-II instrument at a voltage of 200 kV. To observe the vesicles' structure, 500 ìL of solution containing liposomes was spread on parafilm and mixed with 500 ìL of 1 wt% sodium tungstate (maintained at pH 6.8 with 1.0 N KOH) (liposome dispersion/sodium tungstate in 1:1 v/v ratio), a TEM negative stain. After keeping for 2 min, a drop of this solution was placed on carboncoated copper grid and stabilized with carbon film coating. The excess fluid was drained off with filter paper. These TEM grids were then floated on top of deionized water to remove any excess stain. The grids were then wicked and allowed to dry at room temperature before measurement.
Scanning electron microscopy (SEM). SEM measurements were performed on a SU8020 (Hitachi) and NOVA NanoSEM 230 (FEI). The samples for SEM observation were prepared by depositing several drops of the solution (1 mg/mL) onto the surface of clean glass, and the samples were air-dried at room temperature for 24 h.
The samples were coated with a thin film of gold before measuring.
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Methods
Synthesis of uridine acetonide phosphatidylcholine (UPC)
Uridine acetonide (0.80 g, 2.81 mmol) was dissolved in freshly distilled THF (30 mL) and dry TEA (803 μL, 2 eq, 5.71 mmol) was added under nitrogen. The reaction mixture was placed on an ice bath. 2-Chloro-2-oxo-1,3,2-dioxaphospholane (414 μL, 1.6 eq, 4.5 mmol) was slowly added to the mixture while keeping the mixture on an ice bath. Then the reaction mixture was stirred at room temperature for 15 h. Next, the TEA salts were removed by filtration under vacuum at 0 °C. Most of the solvent was evaporated under reduced pressure at 0 °C and 10 mL of the residual solution was used directly without further purification in the following step.
Trimethylamine (2 M solution in THF, 22 mL, 44 mmol) was added to a pressure tube at -78 °C. Then, 10 mL of cold (-20 °C) dry acetonitrile and the solution containing the uridine-oxo-dioxaphospholane were added to the cold trimethylamine solution. The reaction mixture was stirred at 60 °C for 48 h. The product was precipitated in the sealed tube. After evaporation of the solvent at room temperature, the supernatant was removed, and the precipitate obtained was washed in dry acetonitrile. 1.0 g of a hygroscopic solid was obtained after drying under high vacuum 
Synthesis of uridine acetonide phosphatidylethanolamine (UPE)
UPE was synthesized using two different procedures. Procedure 1. Synthesis of 2 was carried out following the same procedure as described above. Then 20 mL of dry acetonitrile and a solution of uridine-oxodioxaphospholane in 10 mL of anhydrous THF were placed in a pressure tube cooled at -78 °C. Subsequently, 87 mL of a solution of ammonia in THF (0.5 M, 43.5 mmol) was added. The pressure tube was sealed and then heated in an oil bath at 65 °C for 48 h. The product was precipitated in the sealed tube. After evaporation of the solvent at room temperature, the supernatant was removed, and the precipitate obtained was washed in dry acetonitrile. 0.9 g of a hygroscopic solid was obtained after drying under high vacuum (Yield: 78 %).
Procedure 2. Phosphorus oxychloride (0.80 g, 2.81 mmol) was dissolved in freshly distilled THF (10 mL) and dry TEA (803 μL, 2 eq, 5.71 mmol) was added under nitrogen. The reaction mixture was placed on an ice bath. A solution of uridine acetonide (0.80 g, 2.81 mmol) in freshly distilled THF (30 mL) was added slowly to the mixture while keeping the mixture on an ice bath. Then the reaction mixture was stirred at room temperature for 2 h. Next, the TEA salts were removed by filtration.
Most of the solvent was evaporated under reduced pressure at 0 °C and 8 mL of the residual solution was used directly without further purification in the following step.
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A solution of ethanolamine (0.19 g, 3.1 mmol) and TEA (1.6 mL, 11.2 mmol) in 10 mL freshly distilled THF was added dropwise to a solution of phosphatidic acid dichloride (5) in 8 mL THF at 10 °C. Then the reaction mixture was stirred at 20 °C for 0.5 h. Next, the reaction mixture was filtered to remove precipitated TEA salts.
Most of the solvent was removed under reduced pressure and the residue was precipitated into hexane and dried under vacuum to a constant weight.
A solution of 6 in 20 mL of 2-propanol was mixed with 10 mL of acetic acid (20% solution in water). After 2 h, most of the solvent was removed under reduced pressure.
The product (4) 14.60 (C24, C38) with carbon atoms as labeled in Figure S4 . HRMS (ESI/Q-TOF):
MH + (theoretical = 672.5064, observed = 672.5043).
Synthesis of 3',5'-dioleoyladenosine (DOA)
2'-Deoxyadenosine (0.50 g, 1.86 mmol) was suspended in anhydrous dichloromethane (25 mL). Then, EDC (0.86 g, 4.46 mmol) was added, followed by oleic acid (1.26 g, 4.46 mmol) and DMAP (0.27 g, 2.23 mmol). The mixture was stirred at room temperature for 20 h. The mixture was then filtered and extracted twice with water, dried with Na 2 SO 4 . The solvent was evaporated on a rotary evaporator, yielding 1.48 g of crude product. The dried product was dissolved in S9 dichloromethane (6 mL). This solution (3 mL) was purified by flash chromatography on a silica column by using a dichloromethane:methanol (20:1) eluent system (Yield: 60% Figure S5 . HRMS (ESI/Q-TOF): MH + (theoretical = 780.6131, observed = 780.6115).
Fabrication of supramolecular liposomes and conventional liposomes
Four kinds of supramolecular liposomes were prepared by mixing equimolar amounts of each component (DMA/UPC, DOA/UPC, DMA/UPE and DOA/UPE) in chloroform/methanol and removing the solvent under reduced pressure. This procedure was repeated for three times, and the resultant complexes were finally dried at in vacuo. Take supramolecular DOA/UPC liposomes for example. Briefly, DOA (7.8 mg) and UPC (4.5 mg) were dissolved in 3 mL of chloroform/methanol (1:1, v/v) in a round-bottomed flask. The solution was evaporated and dried on vacuum for 6 h.
Ultra pure water (6 mL) was added to the flask in an ultrasonic bath (Sheng Yan SCQ S10 3201, 40 kHz, power output 300 W). After a bath sonication for 30 min, an equal volume of PBS (40 mM, pH = 7.4) was added and sonicated for another 5 min.
Similarly, conventional liposomes were prepared with DOPC in the same procedure.
The critical aggregation concentration (CAC) of supramolecular DOA/UPC nucleoside phospholipids was determined using 1,6-diphenyl-1,3,5-hexatriene (DPH)
as UV probe by monitoring the absorbance at 313 nm. The concentration of supramolecular nucleolipids was varied from 5.0×10 -5 to 0.2 mg/mL and the DPH concentration was fixed at 5.0×10 -6 mol/L. The absorbance spectra of all solutions were recorded using Perkin-Elmer Lambda 20/2.0 UV/Vis spectrometer.
Preparation of DOX-loaded supramolecular liposomes and DOXloaded conventional liposomes
The supramolecular DOA:UPC dry-film was prepared in a round-bottomed flask as above mentioned. A predetermined amount of DOX was dissolved in PBS buffer and then added to the flask in an ultrasonic bath (Sheng Yan SCQ 3201, 40 kHz, power output 300 W). Subsequently, the resulting solution was sonicated for 30 min, allowing the lipids to self-assemble into drug-loaded liposomes. The drug-loaded liposomes were purified according to previous report. 1 DOX-loaded liposomes were separated from free DOX by gel filtration using spin Sephadex G50 columns.
Sephadex G50 was presoaked in the isoosmotic KCl buffer with 10 mM HEPES and 1 mM EDTA at pH 7.4. The other three kinds of DOX-loaded supramolecular liposomes and DOX-loaded conventional liposomes were prepared using the same method. The contents inside the dialysis tube were filtered and lyophilized. The 
Cell culture
MCF-7 cells (a human breast adenocarcinoma cell line) and NIH/3T3 normal cells (a mouse embryonic fibroblast cell line) were cultured in DMEM (Dulbecco's S12 modified Eagle's medium) supplied with 10% FBS (fetal bovine serum) and antibiotics (50 units/mL penicillin and 50 units/mL streptomycin) at 37 °C in a humidified atmosphere containing 5% CO 2 .
Biocompatibility of supramolecular liposomes
The relative cytotoxicity of supramolecular liposomes with molecular recognition of nucleobases was estimated by MTT viability assay against NIH/3T3 cells and hemolysis assay. 
Intracellular drug release
The experiments of intracellular drug release were performed on flow cytometry and confocal laser scanning microscopy (CLSM).
Flow Cytometry: MCF-7 cells were seeded in six-well plates at 5×10 5 cells per well in 1 mL complete DMEM and cultured for 24 h. Then the DOX-loaded supramolecular liposomes dissolved in DMEM culture medium at a final DOX concentration of 8 μg/mL were added to different wells and the cells were incubated at 37 °C for 5, 15, 30, and 60 min. Thereafter, culture medium was removed, and cells were washed with PBS twice and treated with trypsin. Subsequently, 2 mL of PBS was added to each culture well, and the solutions were centrifugated for 5 min (1000 rpm). After the supernates were removed, the cells were resuspended in 0.5 mL of PBS. Data for 1.0×10 4 gated events were collected and analysis was performed by S14 means of a BD FACSCalibur flow cytometer and CELLQuest software.
CLSM: MCF-7 cells were seeded in six-well plates at 2×10 5 cells per well in 1 mL complete DMEM and cultured for 24 h, followed by removing culture medium and adding DOX-loaded micelles (1 mL DMEM medium) at a final DOX concentration of 8 μg/mL. The cells were incubated at 37 °C for predetermined intervals. The cells were stained by LysoSensor Green DND-189 for 45 min at 37 °C. Then the culture medium was removed and cells were washed with PBS for three times. Subsequently, the cells were fixed with 4% paraformaldehyde for 30 min at room temperature, and the slides were rinsed with PBS for three times. Finally, the cells were stained with
Hoechst 33342 for 8 min and the slides were rinsed with PBS for three times. The slides were mounted and observed by a LSM 510META.
In vitro cytotoxicity evaluation
The 
Apoptosis analysis with flow cytometry
MCF-7 cells were exposed to DOX-loaded supramolecular liposomes, DOX-loaded conventional liposomes and free DOX at equivalent DOX doses (5 μg/mL) for 24 h.
After that, both floating and attached cells were collected, washed three times with ice-cold PBS, and incubated at 37 °C for 15 min with Annexin V-FITC and propodium iodide (PI) to determine cell apoptosis. The samples were analyzed by flow cytometry (BD LSRFortessa, USA).
Western blotting analysis
MCF-7 cells were seeded in 6-well plates at a density of 5. 
In vivo antitumor efficacy
The tumors were produced in Balb/c male nude mice as described above. Mice were inspected for viewing the tumor appearance by observation and palpation.
Tumor-bearing mice were randomly divided into 5 groups (each 6 mice): 1) the control group; 2) supramolecular liposomes; 3) free DOX (10 mg/kg); 4) DOX-loaded conventional liposomes (DOX, 10 mg/kg); 5) DOX-loaded supramolecular liposomes S18 (DOX, 10 mg/kg). Each sample was injected via the lateral tail vein once every 4 days for 28 days. The volume of tumors and weight of mice were measured before every treatment and the fourth day after the last administration to mice. Antitumor activity was evaluated in terms of tumor size (V = 1/2ab 2 ; a, long diameter; b, short diameter) by measuring two orthogonal diameters at various time points. Animals were sacrificed by cervical dislocation. Tumors were dissected and fixed with formalin for pathological section.
Statistics
All experiments were repeated at least three times. Data are presented as means ± standard deviation. Statistical significance (p<0.05) was evaluated by using Student's t-test when only two groups were compared. If more than two groups were compared, evaluation of significance was performed using one-way analysis of variance (ANOVA) followed by Bonferroni's post hoc test. In all tests, statistical significance was set at p<0.05. error (n = 4), and the statistical significance level is *P < 0.05.
